Related Experiment Video
Updated: Apr 28, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Unusual redo mitral valve replacement for bleeding in Glanzmann thrombasthenia
Ovidio A Garcia-Villarreal1, Ernesto Fernández-Ceseña2, Mercedes Solano-Ricardi3
1Department of Cardiac Surgery, Hospital of Cardiology, UMAE 34, IMSS, Monterrey, Nuevo Leon, Mexico ovidiogv@hotmail.com.
Mechanical mitral valve replacement in a patient with Glanzmann thrombasthenia led to severe bleeding complications. A biological prosthesis was necessary to manage the critical situation, underscoring anticoagulation risks.
Area of Science:
- Cardiology
- Hematology
Background:
- Glanzmann thrombasthenia is a rare inherited platelet disorder.
- Mitral valve regurgitation necessitates valve replacement surgery.
Observation:
- A 23-year-old male with Glanzmann thrombasthenia and mitral regurgitation underwent mechanical mitral valve replacement.
- Post-operative warfarin therapy resulted in life-threatening hemorrhages including hemothorax, pericardial effusion, GI bleeding, and hematuria.
Findings:
- The patient required urgent reoperation with a biological mitral valve prosthesis to control bleeding.
- This case highlights the extreme risk of oral anticoagulation in patients with Glanzmann thrombasthenia.
Implications:
- Mitral valve replacement in Glanzmann thrombasthenia poses significant challenges due to bleeding risks.
- Careful consideration of anticoagulation strategies is crucial for these patients.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse I: Introduction

